Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

MYGN

Myriad Genetics (MYGN)

Myriad Genetics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MYGN
DateTimeSourceHeadlineSymbolCompany
07/17/20247:00AMGlobeNewswire Inc.What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer RiskNASDAQ:MYGNMyriad Genetics Inc
07/11/20248:00AMGlobeNewswire Inc.Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to TestingNASDAQ:MYGNMyriad Genetics Inc
07/09/20248:00AMGlobeNewswire Inc.Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority DateNASDAQ:MYGNMyriad Genetics Inc
07/02/20248:00AMGlobeNewswire Inc.Myriad Genetics Earns 2024 Great Place To Work® Certification™NASDAQ:MYGNMyriad Genetics Inc
06/24/20243:05PMGlobeNewswire Inc.Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the ElectionNASDAQ:MYGNMyriad Genetics Inc
06/11/20247:00AMGlobeNewswire Inc.Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 CountriesNASDAQ:MYGNMyriad Genetics Inc
06/10/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/07/20243:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/06/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MYGNMyriad Genetics Inc
06/04/20244:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/04/20249:32AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
06/04/20248:00AMGlobeNewswire Inc.Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier ScreenNASDAQ:MYGNMyriad Genetics Inc
06/03/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MYGNMyriad Genetics Inc
06/03/20243:05PMGlobeNewswire Inc.Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment ToolNASDAQ:MYGNMyriad Genetics Inc
06/03/202412:48PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
05/30/20244:55PMGlobeNewswire Inc.QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applicationsNASDAQ:MYGNMyriad Genetics Inc
05/23/20245:00PMGlobeNewswire Inc.Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual MeetingNASDAQ:MYGNMyriad Genetics Inc
05/16/20243:05PMGlobeNewswire Inc.New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate CancerNASDAQ:MYGNMyriad Genetics Inc
05/15/20244:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
05/15/20244:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
05/15/20243:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
05/14/20243:26PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
05/13/20243:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
05/13/202411:14AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
 Showing the most relevant articles for your search:NASDAQ:MYGN